Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients. Issue 4 (November 2018) - Metro, Giulio; Giannarelli, Diana; Sidoni, Angelo; Chiari, Rita; Bellezza, Guido